Rchr
J-GLOBAL ID:201301046448732445
Update date: Jul. 19, 2024
HISATAKE MATSUMOTO
マツモト ヒサタケ | HISATAKE MATSUMOTO
Affiliation and department:
Research field (4):
Molecular biology
, Genetics
, Immunology
, Emergency medicine
Research keywords (1):
Clinical Bioinformatics
Research theme for competitive and other funds (19):
- 2023 - 2028 敗血症性脳症の分子病態統合解析と新規生体指標による積極的治療介入方法の提案
- 2023 - 2026 侵襲時再生治療に関する新規制御因子の解明:ゲノム・エピゲノム統合解析
- 2023 - 2026 免疫応答バランスからみた熱傷後の免疫不全メカニズムに関する統合的解析
- 2022 - 2025 網羅的生体分子情報に基づく重症熱傷病態の中心的分子解明と新規治療薬開発
- 2022 - 2025 Immunomolecular pathogenesis of systemic and local lung immunity in ARDS based on integrated analysis
- 2022 - 2025 脂肪細胞による全身性炎症反応制御:オートファジーとアディポカイン産生
- 2022 - 2025 網羅的分子生体情報を用いた頭部外傷患者に対する新たな治療戦略の構築
- 2021 - 2024 シングル細胞シークエンスを用いた敗血症における免疫抑制病態の解明と新規治療法開発
- 2021 - 2024 トランスクリプトームを用いた心停止の分子ネットワーク病態の解明と神経予後予測
- 2020 - 2023 Development of biomarker and molecular pathological classification for optimizing inflammation in sepsis:clinical application of HIVEP1
- 2020 - 2023 Profiling of circulating micro RNA expression in patients with sepsis
- 2019 - 2022 New developments in regenerative therapy for critical illness: the role of novel inflammatory amplification mechanisms.
- 2020 - 2021 新型コロナウイルス感染症(COVID-19)患者の網羅的遺伝子・タンパク発現解析を用いた新規分子病態バイオマーカー開発と臨床応用
- 2020 - トランスクプリトーム解析に基づいた集中治療室における重症患者の新規分子ネットワーク病態解明
- 2016 - 2018 Therapeutic effectiveness of human bone marrow mesenchymal stem cell transplantation in a rat model of crush Injury
- 2015 - 2018 Establishment of methods for immune response analysis of lymphocytes and neutrophils against sepsis and trauma
- 2015 - 2018 Blast induced Traumatic Brain Injury and Cardiovascular Response
- 2014 - 2016 A new therapeutic strategy by suppression of F-actin/DNGR-1 signal in a rat model of crush injury
- 2015 - 転写調整因子HIVEP1を標的と した敗血症におけるNFκBシグナルのメカニズム解明
Show all
Papers (72):
-
Kazuko Uno, Abu Hasan, Emi E Nakayama, Rummana Rahim, Hiromasa Harada, Mitsunori Kaneko, Shoji Hashimoto, Toshio Tanaka, Hisatake Matsumoto, Hitoshi Fujimiya, et al. Predictive biomarkers of COVID-19 prognosis identified in Bangladesh patients and validated in Japanese cohorts. Scientific reports. 2024. 14. 1. 12713-12713
-
Hozaifa Metwally, Maha M Elbrashy, Tatsuhiko Ozawa, Kazuki Okuyama, Jason T White, Janyerkye Tulyeu, Jonas Nørskov Søndergaard, James Badger Wing, Arisa Muratsu, Hisatake Matsumoto, et al. Threonine phosphorylation of STAT1 restricts interferon signaling and promotes innate inflammatory responses. Proceedings of the National Academy of Sciences of the United States of America. 2024. 121. 17. e2402226121
-
Jotaro Tachino, Yuki Togami, Hisatake Matsumoto, Tsunehiro Matsubara, Shigeto Seno, Hiroshi Ogura, Jun Oda. Plasma Proteomics Profile-Based Comparison of Torso Versus Brain Injury: A Prospective Cohort Study. The journal of trauma and acute care surgery. 2024
-
Jotaro Tachino, Shigeto Seno, Hisatake Matsumoto, Tetsuhisa Kitamura, Atsushi Hirayama, Shunichiro Nakao, Yusuke Katayama, Hiroshi Ogura, Jun Oda. Association between tranexamic acid administration and mortality based on the trauma phenotype: a retrospective analysis of a nationwide trauma registry in Japan. Critical care (London, England). 2024. 28. 1. 89-89
-
Risei Fujimoto, Sayaka Oda, Hisatake Matsumoto, Shunichiro Nakao, Kentaro Shimizu, Daisuke Okuzaki, Jun Oda. Longitudinal whole blood transcriptome analysis of a septic shock patient with secondary hemophagocytic syndrome. QJM : monthly journal of the Association of Physicians. 2024
more...
MISC (92):
-
ODA Sayaka, UMEMURA Yutaka, YOSHIMURA Junpei, MITSUYAMA Yumi, MATSUMOTO Hisatake, OKUZAKI Daisuke, OGURA Hiroshi, TANAKA Susumu, ODA Jun. Evaluation of circulating miRNAs that regulate sepsis based on mRNA-microRNA integration analysis. 日本集中治療医学会学術集会(Web). 2024. 51st
-
Jumpei Yoshimura, Yuki Togami, Takeshi Ebihara, Hisatake Matsumoto, Yumi Mitsuyama, Fuminori Sugihara, Haruhiko Hirata, Daisuke Okuzaki, Hiroshi Ogura. Classification of patients with COVID-19 by blood RNA endotype: a prospective cohort study. Microbiology spectrum. 2023. 49th. Suppl.1. e0264523-312
-
松本 寿健. 敗血症のオミックス研究Up-to-date : 新しい分子病態解明と個別化医療への応用-Up-to-date on Omics Research of Sepsis : Elucidation of Novel Molecular Pathogenesis in Sepsis and Its Application to Personalized Medicine-特集 敗血症Up-to-date. ICUとCCU = Japanese journal of intensive care medicine : 集中治療医学. 2023. 47. 11. 715-723
-
松本寿健. Up-to-date on Omics Research of Sepsis: Elucidation of Novel Molecular Pathogenesis in Sepsis and Its Application to Personalized Medicine. ICUとCCU. 2023. 47. 11. 715-723
-
舘野 丈太郎, 松本 寿健, 杉原 文徳, 瀬尾 茂人, 奥崎 大介, 北村 哲久, 小向 翔, 木戸 善之, 兒嶋 嵩, 戸上 由貴, et al. 機械学習による新規外傷フェノタイプの同定とプロテオーム解析を用いた病態考察. 日本集中治療医学会雑誌. 2023. 30. Suppl.1. S456-S456
more...
Patents (4):
Professional career (1):
- MD-PhD (Osaka University)
Awards (3):
- 2022 - Roche INFECTIOUS DISEASE AWARD 2022 Significance of interferon signaling based on mRNA-microRNA integration and plasma protein analyses in critically ill COVID-19 patients.
- 2021 - Roche INFECTIOUS DISEASE AWARD 2022 Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients
- 2017/09 - European Shock Society Young investor award Unraveling the role of HIVEP1 in innate immunity and sepsis
Return to Previous Page